No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Juli Stover Joins eVisit As New Chief Strategy Officer

Telemedicine and healthcare technology expert Stover joins eVisit's C-suite to oversee strategic initiatives aimed at spurring company growth

Editor: What To Know

  • Prior to her time at Envision, Juli Stover served as Vice President of Healthcare Alliances at Vidyo, a software-based technology platform located in Hackensack, New Jersey.
  • “I’m thrilled to be joining eVisit at a pivotal time when patients and clinicians alike have come to value and rely on the model of virtual care,”.
  • “Her robust healthcare experience means she is exactly the caliber of talent we need to support our customers and advance our vision for the future of healthcare.

Juli Stover: eVisit, the leading Virtual Care platform for large healthcare providers, today announced that Juli Stover has joined its leadership team as Chief Strategy Officer. Stover most recently served as Vice President of Virtual Health Strategies at Envision Healthcare, a national hospital-based physician group headquartered in Nashville.

Juli Stover will oversee eVisit’s growth initiatives by contributing to the product roadmap based on customer and market trends, as well as securing strategic partnerships. Stover joins just after eVisit announced its closure of a $45 million Series B financing round led by the Growth Equity business within Goldman Sachs Asset Management.

Prior to her time at Envision, Juli Stover served as Vice President of Healthcare Alliances at Vidyo, a software-based technology platform located in Hackensack, New Jersey. In that role, Stover developed strategic partnerships to drive organizational growth while also collaborating on partner enablement plans to scale adoption.

Stover’s other leadership roles included Vice President of Telehealth and Innovative Health Solutions at Corizon Health, multiple leadership positions at InTouch Health (now part of Teladoc), and HCA Healthcare.

“I’m thrilled to be joining eVisit at a pivotal time when patients and clinicians alike have come to value and rely on the model of virtual care,” said Stover. “I’ve been working in the healthcare industry for many years and view this new role as an opportunity to advance patient care through telehealth and data analytics.”

Stover attended Auburn University and graduated from Troy University with a Bachelor of Science degree in Human Services and Marketing.

“We are excited to welcome Juli Stover to eVisit’s C-suite,” said Bret Larsen, CEO of eVisit. “Her robust healthcare experience means she is exactly the caliber of talent we need to support our customers and advance our vision for the future of healthcare. As we head into 2022, we are eager to add Juli’s expertise to eVisit’s incredible momentum.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy